Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

PropertyValue
has major subject area list Antibodies, Monoclonal; Carcinoma; Fallopian Tube Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms

Search Criteria
  • Fallopian Tube Cancer